No probs Vyking, glad to have this discussion with you. If we all share info and views then we can only benefit from that.
Yes it will be a bummer if complete trials need to be redone with TETS attached and I agree that shareholders probably haven't included TETS in VCR's share price yet. It is still very much an unknown factor. But we know VCR have been working on it for some time and putting the $$$ into R&D so let's hope they can come up with the goods!
cheers
- Forums
- ASX - By Stock
- VCR
- 150th implant
VCR
ventracor limited